- $75.86bn
- $64.18bn
- CNY276.74bn
- 89
- 43
- 65
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 97,529 | 114,795 | 179,128 | 219,955 | 276,745 |
Cost of Revenue | |||||
Gross Profit | 32,320 | 34,050 | 42,474 | 61,753 | 97,191 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 94,849 | 110,464 | 202,255 | 225,775 | 263,330 |
Operating Profit | 2,680 | 4,330 | -23,127 | -5,820 | 13,415 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,762 | 4,438 | -23,566 | -6,756 | 14,022 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,236 | 4,708 | -23,536 | -6,685 | 13,857 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,239 | 4,708 | -23,538 | -6,686 | 13,856 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,251 | 4,708 | -23,538 | -6,686 | 13,856 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.462 | 0.768 | -3.57 | -1.05 | 2.38 |